Management and Operations team
Emma Höglund,
CEO
Philip Novak,
Co-founder
Philipp Novak holds a doctorate in veterinary medicine and an MSc in pharmaceutical medicine and has more than 14 years of industry experience. Philipp is the CEO and founder of Orphanix GmbH, a firm for niche and orphan medical treatments.
Stefan Johansson,
CMO & Co-founder
Vera Westin,
Customer Support Manager
Vera Westin is a dietitian and worked at the Karolinska University Hospital between 1980 and 2018. She holds a Ph.D. in neonatal nutrition. She has expertise in preterm infants’ nutrition and growth.
Frank Alkenbrecher,
European Sales Manager
Caroline Boström,
Product Manager NeoMega36®
Dóra Markó,
Financial Controller
Carla Martino,
Regional Sales Manager, Italy
Carla Martino holds an MSc in Industrial Biotechnology from the University of Milano-Bicocca and a postgraduate specialization in pharmaceutical marketing and management from ISTUM Institute, Italy. She has over 3 years of experience in the pharmaceutical industry in different therapeutic areas.
Emma Zimmermann,
Regional Sales Manager, UK
Emma Zimmermann is a registered midwife with over 10 years of clinical experience. In addition to her healthcare expertise, Emma brings extensive sales and marketing experience from her successful career in the medical device industry.
Vesa Loponen,
Business Consultant
Isac Blomberg,
Business & Sales Analyst
Annika Wülfing
Strategic Scientific Affairs Lead
Board of Directors
Mårten Österlund
Mårten Österlund has a PhD from Uppsala University and post doctorate studies at the Pasteur Institute in Paris, France. He spent his working years in various leading positions at a number of pharmaceutical companies such as Karo Bio, Affibody and Meda. With extensive knowledge from the pharmaceutical market and having participated in research and clinical development of pharmaceuticals and documented knowledge in successful launches of innovative products. In 2018 Mårten Österlund founded Pharma Way AB.
Stefan Johansson (chairman)
Stefan Johansson, also CEO, is a Consultant Neonatologist and Associate Professor, and holds a PhD in epidemiology and biostatistics at Karolinska Institutet. In addition to be a social entrepreneur, being founder of 99nicu.org and ebneo.org, he has vast knowledge in research design and works in several large-scale projects. With his methodological expertise, Stefan Johansson has published on a large variety of research topics, including very preterm birth, maternal obesity, patent ductus arteriosus, neonatal jaundice, Down syndrome and birth asphyxia.
Kristina Magnusson Borg
Kristina Magnusson Borg has worked more than 35 years within the pharmaceutical and probiotic industries. Her experience ranges from basic and clinical research, business development to marketing & sales in senior and strategic positions on a global market. Kristina holds a Ph Licentiate degree in Medical Science, Karolinska Institute, as well as an Executive MBA.
Philipp Novak
Philipp Novak, also COO, holds a doctorate in veterinary medicine and an MSc in pharmaceutical medicine, and has more than 14 years of industry experience, involving global roles in Research & Development and Innovation. Philipp Novak is also CEO and founder of orphanix GmbH, a development firm for medical treatments of rare and neglected disease